| Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial M Alberer, U Gnad-Vogt, HS Hong, KT Mehr, L Backert, G Finak, ... The Lancet 390 (10101), 1511-1520, 2017 | 546 | 2017 |
| Immunoinformatics and epitope prediction in the age of genomic medicine L Backert, O Kohlbacher Genome medicine 7, 1-12, 2015 | 252 | 2015 |
| HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy A Marcu, L Bichmann, L Kuchenbecker, DJ Kowalewski, ... Journal for immunotherapy of cancer 9 (4), 2021 | 196 | 2021 |
| The immunopeptidomic landscape of ovarian carcinomas H Schuster, JK Peper, HC Bösmüller, K Röhle, L Backert, T Bilich, B Ney, ... Proceedings of the National Academy of Sciences 114 (46), E9942-E9951, 2017 | 193 | 2017 |
| HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL) DJ Kowalewski, H Schuster, L Backert, C Berlin, S Kahn, L Kanz, ... Proceedings of the National Academy of Sciences 112 (2), E166-E175, 2015 | 192 | 2015 |
| The antigenic landscape of multiple myeloma: mass spectrometry (re) defines targets for T-cell–based immunotherapy S Walz, JS Stickel, DJ Kowalewski, H Schuster, K Weisel, L Backert, ... Blood, The Journal of the American Society of Hematology 126 (10), 1203-1213, 2015 | 128 | 2015 |
| AureoWiki ̵ The repository of the Staphylococcus aureus research and annotation community S Fuchs, H Mehlan, J Bernhardt, A Hennig, S Michalik, K Surmann, ... International journal of medical microbiology 308 (6), 558-568, 2018 | 123 | 2018 |
| Unveiling the peptide motifs of HLA-C and HLA-G from naturally presented peptides and generation of binding prediction matrices M Di Marco, H Schuster, L Backert, M Ghosh, HG Rammensee, ... The Journal of Immunology 199 (8), 2639-2651, 2017 | 109 | 2017 |
| A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer HG Rammensee, KH Wiesmüller, PA Chandran, H Zelba, E Rusch, ... Journal for immunotherapy of cancer 7, 1-18, 2019 | 76 | 2019 |
| Mapping the HLA ligandome of colorectal cancer reveals an imprint of malignant cell transformation MW Löffler, DJ Kowalewski, L Backert, J Bernhardt, P Adam, H Schuster, ... Cancer research 78 (16), 4627-4641, 2018 | 66 | 2018 |
| The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy MC Neidert, DJ Kowalewski, M Silginer, K Kapolou, L Backert, ... Acta neuropathologica 135, 923-938, 2018 | 49 | 2018 |
| HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell … A Nelde, DJ Kowalewski, L Backert, H Schuster, JO Werner, R Klein, ... Oncoimmunology 7 (4), e1316438, 2018 | 47 | 2018 |
| Integrative-omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy A Reustle, M Di Marco, C Meyerhoff, A Nelde, JS Walz, S Winter, ... Genome medicine 12, 1-24, 2020 | 44 | 2020 |
| The HLA Ligand Atlas: A novel immuno-oncology resource for T-cell antigen discovery. A Marcu, L Bichmann, L Kuchenbecker, L Backert, DJ Kowalewski, ... Journal of Clinical Oncology 38 (15_suppl), 3128-3128, 2020 | 40* | 2020 |
| Pitfalls in HLA ligandomics—how to catch a li (e) gand J Fritsche, DJ Kowalewski, L Backert, F Gwinner, S Dorner, M Priemer, ... Molecular & Cellular Proteomics 20, 2021 | 29 | 2021 |
| Characterization of the canine MHC class I DLA-88* 50101 peptide binding motif as a prerequisite for canine T cell immunotherapy SM Barth, CM Schreitmüller, F Proehl, K Oehl, LM Lumpp, DJ Kowalewski, ... PLoS One 11 (11), e0167017, 2016 | 28 | 2016 |
| Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini DJ Kowalewski, S Walz, L Backert, H Schuster, O Kohlbacher, K Weisel, ... Blood Cancer Journal 6 (4), e411-e411, 2016 | 24 | 2016 |
| Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy HS Hong, SD Koch, B Scheel, U Gnad-Vogt, A Schröder, KJ Kallen, ... Oncoimmunology 5 (12), e1249560, 2016 | 22 | 2016 |
| Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation SP Haen, C Groh, M Schumm, L Backert, MW Löffler, B Federmann, ... Annals of hematology 96, 817-827, 2017 | 19 | 2017 |
| A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and “pan-leukemia” antigens L Backert, DJ Kowalewski, S Walz, H Schuster, C Berlin, MC Neidert, ... Oncotarget 8 (27), 43915, 2017 | 14 | 2017 |
Michael RömerImmatics Biotechnologies, Tübingen, GermanyVerified email at immatics.com